Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 1, 2013, Pages 85-93

  Strydom, Schalk J ^a,b   Rose, Warren E ^a   Otto, Daniel P ^b   Liebenberg, Wilna ^b   De Villiers, Melgardt M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Antibacterial; PAMAM dendrimer; Release; Silverantibiotic nanoparticles; Solubility

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL; ANTIBACTERIAL PROPERTIES; AQUEOUS SOLUBILITY; BOTTOM UP APPROACH; DENDRIMER COMPLEXES; LAYER-BY-LAYERS; PAMAM DENDRIMER; POLY(AMIDO AMINE); RELEASE; SILVER SULFADIAZINES;

CRYSTAL GROWTH; DENDRIMERS; NANOPARTICLES; SOLUBILITY; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

SILVER;

DENDRIMER; POLYAMIDOAMINE; SILVER NANOPARTICLE; SILVER SULFONAMIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CRYSTALLIZATION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; NONHUMAN; STATIC ELECTRICITY;

ANTI-BACTERIAL AGENTS; DENDRIMERS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYAMINES; SILVER;

EID: 84871405125     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.03.006     Document Type: Article

References (40)

1. Kooistra-Smid M., Nieuwenhuis M., Van Belkum A., Verbrugh H. The role of nasal carriage in Staphylococcus areus burn wound colonization. FEMS Immunol Med Microbiol 2009, 57:1-13.
2. Alexander J.W. Pathophysiologic events related to thermal injury of skin. J Trauma 1990, 30:S70-S75.
3. Erol S., Altoparlak U., Akcay M.N., Celebi F., Parlak M. Changes of microbial flora and wound colonization in burned patients. Burns 2004, 30:357-361.
4. Fox C.L. Silver sulfadiazine - a new topical therapy for Pseudomonas in burns. AMA Arch Surg 1968, 96:184-188.
5. Fox C.L., Modak S.M. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 1974, 5:582-588.
6. Tomalia D.A., Naylor A.M., Goddard W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Intl Eng Ed 1990, 29:138-175.
7. Bielinska A., Kukowska-Latallo J.F., Johnson J., Tomalia D.A., Baker J.R. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res 1996, 24:2176-2182.
8. Calabretta M.K., Kumar A., McDermott A.M., Cai C. Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups. Biomacromolecules 2007, 8:1807-1811.
9. Svenson S., Tomalia D.A. Dendrimers in biomedicalapplications - reflections on the field. Adv Drug Delivery Rev 2005, 57:2106-2129.
10. Devarakonda B., Hill R.A., Liebenberg W., Brits M., De Villiers M.M. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int J Pharm 2005, 304:193-209.
11. Menjoge A.R., Kannan R.M., Tomalia D.A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discovery Today 2010, 15:171-185.
12. Devarakonda B., Judefeind A., Chigurupati S., Thomas S., Shah G.V., Otto D.P., De Villiers M.M. Theeffect of polyamidoaminedenrimersonthe in vitro cytotoxicity of paclitaxel in cultured prostate cancer (PC-3M) cells. J Biomed Nanotechnol 2007, 3:384-393.
13. Ma M., Cheng Y., Xu Z., Xu P., Qu H., Fang Y., Xu T., Wen L. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur J Med Chem 2007, 42:93-98.
14. Shaffer C. Nanomedicine transforms drug delivery. Drug Discovery Today 2005, 10:1581-1582.
15. Bult A., Plug C.M. Silver Sulfadiazine. Analytical Profiles of Drug Substances 1984, Vol. 13:553-571. Academic Press, New York. K. Florey (Ed.).
16. Kéki S., Török J., Deák G., Daróczi L., Zsuga M.J. Silver nanoparticles by PAMAM-assisted photochemical reduction of Ag(+). Colloid Interface Sci 2000, 229:550-553.
17. Prieto M.J., Bacigalupe D., Pardini O., Amalvy J.I., Venturini C., Morilla M.J., Romeo E.L. Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent. Int J Pharm 2006, 326:160-168.
18. Jin L., Yang S.P., Wu H.X., Huang W.W., Tian Q.W. Preparation and characterization of silver nanoparticles with dendrimers as templates. J Appl Polym Sci 2008, 108:4023-4028.
19. Wang B.B., Zhang X., Jia X.R., Li Z.C., Ji Y., Yang L., Wie Y. Fluorescence and aggregation beahvior of poly(amidoamine) dendrimers peripherally modified with aromatic chromophores: the effect of dendritic architectures. J Am Chem Soc 2004, 126:15180-15194.
20. Jasmine M.J., Kavitha M., Prasad E. Effect of solvent-controlled aggregation on the intrinsic emission properties of PAMAM dendrimers. J Luminescence 2009, 129:506-513.
21. Topp A., Bauer B.J., Prosa T.J., Scherrenberg R., Amis E.J. Size change of dendrimers in concentrated solution. Macromolecules 1999, 32:8923-8931.
22. Carbone P., Müller-Plathe F. Molecular dynamics simulations of polyaminoamide (PAMAM) dendrimer aggregates: molecular shape, hydrogen bonds and local dynamics. Soft Matter 2009, 5:2638-2647.
23. Nesamony J., Kolling W.M. IPM/DOSS/water microemulsions as reactors for silver sulfadiazine nanocrystal synthesis. J Pharm Sci 2005, 94:1310-1320.
24. Wu T., Sun Y., Li N., De Villiers M.M., Yu L. Inhibiting surface crystallization of amorphous indomethacin by nanocoating. Langmuir 2007, 23:5148-5153.
25. Strydom S.J., Otto D.P., Liebenberg W., Lvov Y.M., De Villiers M.M. Preparation and characterization of directly compactible layer-by-layer nanocoated cellulose. Int J Pharm 2011, 404:57-66.
26. Khopade A.J., Caruso F. Electrostatically assembled polyelectrolyte/dendrimer multilayer films as ultrathin nanoreservoirs. Nano Lett 2002, 2:415-418.
27. Ai H., Jones S.A., De Villiers M.M., Lvov Y.M. Nano-encapsulation of furosemide microcrystals for controlled drug release. J Control Release 2003, 86:59-68.
28. Tsukruk V.V., Rinderspacher F., Bliznyuk V.N. Self-assembled films from dendrimers. Langmuir 1997, 13:2171-2176.
29. Khopade A.J., Caruso F. Investigation of the factors influencing the formation of dendrimer/polyanionmultilayer films. Langmuir 2002, 18:7669-7676.
30. Li L., Cao X., Yu F., Yao Z., Xie Y. G1 dendrimers-mediated evolution of silver nanostructures from nanoparticles to solid spheres. J Colloid Interface Sci 2003, 261:366-371.
31. Vergnaud J.M. Controlled Drug Release of Oral Dosage Forms 1993, 346. Ellis Horwood, New York.
32. Stober H., DeWitte W. In: Analytical Profiles of Drug Substances 1984, Vol. 11:523-551. Academic Press, New York. K. Florey (Ed.).
33. Liu Z., Wang X., Wu H., Li C. Silver nanocomposite layer-by-layer films based on assembled polyelectrolyte/dendrimer. J Colloid Interface Sci 2005, 287:604-611.
34. Shutava T., Prouty M., Kommireddy D., Lvov Y. pH responsive decomposable layer-by-layer nanofilms and capsules on the basis of tannic acid. Macromolecules 2005, 38:2850-2858.
35. Fraser J.F., Bodman J., Sturgess R., Faoagali J., Kimble R.M. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 2004, 30:35-41.
36. Busch N.A., Zanzot E.M., Loiselle P.M., Carter E.A., Allaire J.E., Yarmush M.L., Warren H.S. A model of infected burn wounds using Escherichia coli O18:K1:H7 for the study of gram-negative bacteremia and sepsis. Infect Immun 2000, 68:3349-3351.
37. Balogh L., Swanson D.R., Tomalia D.A., Hagnauer G.L., McManus A.T. Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano Lett 2001, 1:18-21.
38. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramíres J.T., et al. The bacterial effects of silver nanoparticles. Nanotechnol 2005, 16:2346-2353.
39. Kim J.S., Kuk E., Yu K.N., Kim J.H., Park S.J., Lee H.J., et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 2007, 3:95-101.
40. Richards R.M.E., Xing D.K.L. Evaluation of synergistic effects of combinations of antibacterials having relevance on burn wound infections. Int J Pharm 1991, 75:81-87.